NRXN1 and schizophrenia: The ULK4 CNVs occur at a rate of 0.14% (16/11,633) from two previous studies7,8, lower than NRXN1 CNVs as a major target for schizophrenia (0.18–0.63%)24–26, and ASD (0.45%)27,28.